TGFBR1 and T-cell non-Hodgkin lymphoma: To a lesser extent, mutations in TGFBR1 (TβRI, TGFβ Type I receptor) have been revealed in ovary, breast and pancreatic cancer or T cell lymphoma, as well as related to the growth of skin tumors in the Ferguson-Smith disease, a multiple self-healing squamous epithelioma [15,16,17,18].